Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-09-20

FDA Approved: ELMIRON — Supplemental Application (Janssen Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ELMIRON (pentosan polysulfate sodium) from Janssen Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Elmiron (pentosan polysulfate sodium)

Snippet

SUPPL AP for ELMIRON (PENTOSAN POLYSULFATE SODIUM)